New research has identified human antibodies that target the measles virus, which could help in the development of treatments for the virus, officials said on May 14.
“With measles cases increasing, we urgently need effective therapeutics to protect the most vulnerable,” Dr. Jeffrey Taubenberger, acting director of National Institute of Allergy and Infectious Diseases, part of the National Institute of Health (NIH), said in a statement.





